198 related articles for article (PubMed ID: 31437010)
1. Sublingual immunotherapy of atopic dermatitis in mite-sensitized patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Liu L; Chen J; Xu J; Yang Q; Gu C; Ni C; Li L; Lu X; Yao Z; Tao J; Guo Y; Fang H; Ding Y; Qian Q; Zhou N; Wang M; Deng D; Xie H; Li S; Huang Y; Zhao N; Zheng M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3540-3547. PubMed ID: 31437010
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Langer SS; Cardili RN; Melo JML; Ferriani MPL; Moreno AS; Dias MM; Bueno-Filho R; Pocente RHC; Roxo-Junior P; Silva J; Valera FCP; Coelho EB; Galvão CES; Carmona F; Aragon DC; Arruda LK
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):539-549.e7. PubMed ID: 34767999
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation for sublingual immunotherapy of allergic asthma and atopic rhinitis with Dermatophagoides Farinae Drops].
Cao LF; Lu Q; Gu HL; Chen YP; Zhang Y; Lu M; Qian YQ; Li L; Xu YP
Zhonghua Er Ke Za Zhi; 2007 Oct; 45(10):736-41. PubMed ID: 18211754
[TBL] [Abstract][Full Text] [Related]
5. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial.
Demoly P; Corren J; Creticos P; De Blay F; Gevaert P; Hellings P; Kowal K; Le Gall M; Nenasheva N; Passalacqua G; Pfaar O; Tortajada-Girbés M; Vidal C; Worm M; Casale TB
J Allergy Clin Immunol; 2021 Mar; 147(3):1020-1030.e10. PubMed ID: 32890575
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and compliance of sublingual immunotherapy with Dermatophagoides farinae drops in patients with atopic dermatitis.
Qin YE; Mao JR; Sang YC; Li WX
Int J Dermatol; 2014 May; 53(5):650-5. PubMed ID: 23968339
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of sublingual immunotherapy with Dermatophagoides farinae vaccine in a murine atopic dermatitis model.
Liu L; Guo D; Liang Q; Ding S; Wu B; Zhang L; Li Q
Clin Exp Allergy; 2015 Apr; 45(4):815-22. PubMed ID: 25258013
[TBL] [Abstract][Full Text] [Related]
10. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study.
Pajno GB; Caminiti L; Vita D; Barberio G; Salzano G; Lombardo F; Canonica GW; Passalacqua G
J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in monosensitized and polysensitized patients with allergic rhinitis].
Chen BY; Long ZM; Huang YJ; Zeng JM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):549-54. PubMed ID: 24313202
[TBL] [Abstract][Full Text] [Related]
13. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma.
Zhong C; Yang W; Li Y; Zou L; Deng Z; Liu M; Huang X
Ir J Med Sci; 2018 May; 187(2):441-446. PubMed ID: 29032417
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis.
Tang LX; Yang XJ; Wang PP; Ge WT; Zhang J; Guo YL; Lu J; Tai J; Zhang YM; Ni X
Allergol Immunopathol (Madr); 2018; 46(2):107-111. PubMed ID: 29331618
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial.
Demoly P; Emminger W; Rehm D; Backer V; Tommerup L; Kleine-Tebbe J
J Allergy Clin Immunol; 2016 Feb; 137(2):444-451.e8. PubMed ID: 26292778
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.
Bahçeciler NN; Işik U; Barlan IB; Başaran MM
Pediatr Pulmonol; 2001 Jul; 32(1):49-55. PubMed ID: 11416876
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
[TBL] [Abstract][Full Text] [Related]
20. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.
Guez S; Vatrinet C; Fadel R; André C
Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
